Everything you need to know to stay updated on the financial market. Information, trend and graph in real time on the stock exchange quotations of the major stocks on world stock exchanges.
ISIN code: US60770K1079
Pharmaceutical industry
Industry: Biotechnology
Moderna's shares are traded on the New York Nasdaq market under the ticker MRNA.
See the stock's listing history on the Nasdaq
Company Description
Moderna is a US company founded in 2010 by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien with headquarters in Cambridge (Massachusetts) and listed on the Nasdaq. Work in biotechnology, particularly active in the research and development of medicines based onRNA messenger (mRNA). Moderna is committed to the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its products include: prophylactic vaccines, cancer vaccines, intratumor immuno-oncology, localized regenerative therapies, secreted systemic therapies, and intracellular systemic therapies. On November 16, 2020, the company announced the development of mRNA-1273, an RNA vaccine to address the COVID-19 pandemic, for which it claimed 94,5% efficacy.
Economic and financial analysis
Moderna has recently formed business relationships with other companies that have influenced its stock. In 2019, it entered into an agreement with Vertex Pharmaceuticals worth more than $300 million potentially to develop mRNA-based therapies for the treatment of cystic fibrosis. Also in the same year there was another important partnership with the Merck group worth 200 million dollars. The aim is to increase the research and development of personalized mRNA-based cancer vaccines.
Since 2020, the Moderna share price has undergone continuous fluctuations linked to the news regarding the vaccine used in the emergency Covid. We have seen how the value of the Moderna share undergoes a significant increase when positive news related to the effectiveness of the vaccine is released. The value of the share is subject to significant variations as Moderna is a company that deals with scientific research and is subject to multiple external factors of a political, social and economic nature.
